The meeting would have been requested by IMU, FDA approval is part of the regulatory process for approval of all new human treatments/device usage in the USA. The announcement suggests there is a clear plan for further development of the PD-1 vaccine, with no unforseen regulatory hurdles to be overcome. The time frame from initiation to final approval can take as long as 9-12 months, but is essential for human trials using the PD-1 vaccine. Successful negotiation of this process will remove a major barrier for external party risk in investment in the technology.Its definitely a step in the right direction, it suggests the management of the company have a clear understanding of the process involved, with no unexpected issues identified in the pre submission meeting.
- Forums
- ASX - By Stock
- Ann: IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx
The meeting would have been requested by IMU, FDA approval is...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $386.7M |
Open | High | Low | Value | Volume |
4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 176601 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 969572 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5665336 | 0.018 |
14 | 3997559 | 0.017 |
6 | 2974375 | 0.016 |
10 | 3219799 | 0.015 |
4 | 497500 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 400000 | 2 |
0.020 | 5410946 | 12 |
0.021 | 8494780 | 17 |
0.022 | 8757253 | 13 |
0.023 | 4826614 | 8 |
Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |